Thermo Fisher CHF notes win A rating as company pursues capital structure optimization
Thermo Fisher Scientific is moving ahead with a CHF Notes issuance as it seeks to optimize its capital structure without weakening its balance sheet. The planned debt sale carries an 'A' rating from Fitch Ratings, underscoring the company's market strength in life sciences and laboratory equipment.
Highlights
- Fitch Ratings assigns 'A' rating to Thermo Fisher Scientific Inc.'s CHF Notes, citing strong business profile and steady free cash flow.
- Thermo Fisher will use proceeds from the CHF Notes for general corporate purposes, including refinancing debt and funding potential acquisitions.
- Fitch highlights Thermo Fisher's successful acquisition integration and profitability, reinforcing lender confidence and sector emphasis on scale and cash generation.
Rating rationale and use of proceeds
As reported by Fitch Ratings, the 'A' rating on Thermo Fisher Scientific Inc.'s CHF Notes reflects a strong business profile built on the company's leading position in the life sciences and laboratory equipment sectors. The agency also points to consistent revenue growth and solid free cash flow generation as key supports for the credit assessment.Thermo Fisher says proceeds from the notes are intended for general corporate purposes. These uses may include refinancing existing debt and supporting future acquisitions, while the company continues to manage its capital structure.
Credit profile and sector implications
Fitch says Thermo Fisher's record of integrating acquisitions and preserving profitability further strengthens its credit profile. The agency remains optimistic about the company's ability to manage debt levels appropriately while continuing to invest in growth opportunities.The rating signals continued lender confidence in one of the largest players in the life sciences tools market. For the sector, the assessment highlights how scale, recurring cash generation and acquisition execution remain important factors in maintaining strong access to capital.
In our earlier coverage of Fitch’s rating of Hainan Rubber’s proposed subordinated perpetual securities, we explained how the planned Halcyon Agri issuance was positioned as part of an offshore refinancing effort. We also outlined why Fitch notched the instrument below the issuer rating due to its subordinated ranking and coupon-deferral features, alongside the agency’s view of leverage, liquidity, and implied state-related support.
Latest Thermo Fisher Scientific News
-
Afghanistan
-
Albania
-
Algeria
-
Angola
-
Argentina
-
Armenia
-
Australia
-
Austria
-
Azerbaijan
-
Bahamas
-
Bahrain
-
Bangladesh
-
Belarus
-
Belgium
-
Bolivia
-
Botswana
-
Brazil
-
Brunei
-
Bulgaria
-
Cambodia
-
Cameroon
-
Canada
-
Chile
-
China
-
Colombia
-
Congo
-
Costa Rica
-
Cote d'Ivoire
-
Croatia
-
Cuba
-
Cyprus
-
Czechia
-
DR Congo
-
Denmark
-
Dominican Republic
-
Ecuador
-
Egypt
-
El Salvador
-
Estonia
-
Eswatini
-
Ethiopia
-
Finland
-
France
-
Georgia
-
Germany
-
Ghana
-
Greece
-
Haiti
-
Hong Kong
-
Hungary
-
India
-
Indonesia
-
Iran, Islamic republic
-
Iraq
-
Ireland
-
Israel
-
Italy
-
Jamaica
-
Japan
-
Jordan
-
Kazakhstan
-
Kenya
-
Korea
-
Kuwait
-
Kyrgyzstan
-
Laos
-
Latvia
-
Lebanon
-
Lesotho
-
Libya
-
Lithuania
-
Luxembourg
-
Madagascar
-
Malaysia
-
Malta
-
Mauritius
-
Mexico
-
Moldova
-
Mongolia
-
Montenegro
-
Morocco
-
Mozambique
-
Myanmar
-
Namibia
-
Nepal
-
Netherlands
-
New Zealand
-
Nigeria
-
North Macedonia
-
Norway
-
Oman
-
Pakistan
-
Palestine
-
Panama
-
Papua New Guinea
-
Paraguay
-
Peru
-
Philippines
-
Poland
-
Portugal
-
Puerto Rico
-
Qatar
-
Reunion
-
Romania
-
Rwanda
-
Saudi Arabia
-
Serbia
-
Singapore
-
Slovakia
-
Slovenia
-
Somalia
-
South Africa
-
Spain
-
Sri Lanka
-
Sweden
-
Switzerland
-
Syria
-
Taiwan
-
Tajikistan
-
Tanzania
-
Thailand
-
Trinidad and Tobago
-
Tunisia
-
Turkey
-
UAE
-
Uganda
-
Ukraine
-
United Kingdom
-
United States
-
Uruguay
-
Uzbekistan
-
Venezuela
-
Vietnam
-
Yemen
-
Zambia
-
Zimbabwe
- Forex
- Crypto
